138 related articles for article (PubMed ID: 17767333)
21. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.
Struewing JP; Hyams KC; Tueller JE; Gray GC
Am J Public Health; 1993 Dec; 83(12):1717-20. PubMed ID: 8259801
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
23. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: comparison with self-reported history.
Fung LW; Lao TT; Suen SS; Chan OK; Lau TK; Ngai KL; Chan PK; Leung TY
Vaccine; 2011 Oct; 29(46):8186-8. PubMed ID: 21911021
[TBL] [Abstract][Full Text] [Related]
25. The seroepidemiology of varicella in Italy.
Gabutti G; Penna C; Rossi M; Salmaso S; Rota MC; Bella A; Crovari P;
Epidemiol Infect; 2001 Jun; 126(3):433-40. PubMed ID: 11467800
[TBL] [Abstract][Full Text] [Related]
26. Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRC.
Suo L; Lu L; Chen M; Pang X
BMC Infect Dis; 2015 Nov; 15():509. PubMed ID: 26554449
[TBL] [Abstract][Full Text] [Related]
27. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
[TBL] [Abstract][Full Text] [Related]
28. Varicella zoster virus immunity in multinational health care workers of a Saudi Arabian hospital.
Almuneef M; Dillon J; Abbas MF; Memish Z
Am J Infect Control; 2003 Oct; 31(6):375-81. PubMed ID: 14608306
[TBL] [Abstract][Full Text] [Related]
29. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
[TBL] [Abstract][Full Text] [Related]
30. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
31. Varicella seroprevalence among health care workers in Korea: validity of self-reported history and cost-effectiveness of prevaccination screening.
Kang JH; Park YS; Park SY; Kim SB; Ko KP; Seo YH
Am J Infect Control; 2014 Aug; 42(8):885-7. PubMed ID: 25087140
[TBL] [Abstract][Full Text] [Related]
32. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
33. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
Perez-Farinos N; Garcia-Comas L; Ramirez-Fernandez R; Sanz JC; Barranco D; Garcia-Fernandez C; Ordobas M
Cent Eur J Public Health; 2008 Mar; 16(1):41-4. PubMed ID: 18459480
[TBL] [Abstract][Full Text] [Related]
35. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
Waclawski ER; Stewart M
Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
[TBL] [Abstract][Full Text] [Related]
37. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore.
Fatha N; Ang LW; Goh KT
Int J Infect Dis; 2014 May; 22():73-7. PubMed ID: 24269652
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
39. Seroepidemiology of varicella-zoster virus in Korea.
Lee H; Cho HK; Kim KH
J Korean Med Sci; 2013 Feb; 28(2):195-9. PubMed ID: 23400233
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of varicella zoster antibodies among children with malnutrition, malignancies and HIV infection.
Admani B; Macharia WM; Were F
East Afr Med J; 2008 Oct; 85(10):480-6. PubMed ID: 19537424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]